A qualitative and quantitative assessment of the application and use of topical acne medication by patients

Cutis

Volumn 76, Issue 2, 2005, Pages 109-113

  Del Rosso, James Q ^{a,b,c,d,e,f,g}  

^a UNIVERSITY OF NEVADA   (United States)

^b Laboratories Ltd   (United States)

^c Galderma Laboratories   (United States)

^d Electronic Sensor Technology LP   (United States)

^e Medicis Pharmaceutical Corporation   (United States)

^f Stiefel Laboratories Inc   (United States)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24744439507     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. Del Rosso JQ. A qualitative and quantitative assessment of the application and consumption of topical acne medication by patients. Poster presented at: 63rd Annual Meeting of the American Academy of Dermatology; February 2005; New Orleans, La. P106.
2. Eady AE, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers. Am J Clin Dermatol. 2003;4:813-831.
3. Berman B, Ricotti CA Jr, Cazzaniga A, et al. Determination of the area of skin capable of being covered by the application of 250 mg of 5% imiquimod cream. Dermatol Surg. 2004;30:784-786.
4. Shelley WB, Shelley ED. The "K" test for dosage of topical medication. Cutis. 1997;60:40.
5. Habif TP. Topical therapy and topical corticosteroids. In: Habif TP, ed. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 4th ed. Philadelphia, Pa: Mosby; 2004:27.
6. Long CC, Finlay AY, Averill RW. The rule of hand: 4 hand areas = 2 FTU = 1 g. Arch Dermatol 1992;128:1129-1130.
7. Ivens UI, Steinkjer B, Serup J, et al. Ointment is evenly spread on the skin, in contrast to creams and solutions. Br J Dermatol. 2001;145:264-267.